Metagenomi Inc.

NASDAQ:MGX

1.67

+0.06 (+3.73%)

4:36:44 PM EDT: $1.70 +0.03 (+1.69%)

Market Cap (Intraday)	64.76M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$8.45 Million
Adjusted EPS	-$0.62

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Metagenomi Inc. Stock, NASDAQ:MGX

5959 Horton Street, 7th floor, Emeryville, California 94608

United States of America

Phone: +1.510.871.4880

Number of Employees: 202

http://www.metagenomi.co

Description

Metagenomi, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene editÃ?Âing toolbox, therÃ?ÂaÃ?ÂpeuÃ?Âtic focus, and processing discovery platform. The company was founded by Brian C. Thomas on September 16, 2016 and is headquartered in Emeryville, CA.